Ruconest 2100 U/1
c1 esterase inhibitor recombinant · INJECTION, POWDER, FOR SOLUTION · Pharming Healthcare Inc.
Ruconest is a injection, powder, for solution containing c1 esterase inhibitor recombinant at 2100 U/1, taken intravenous. Manufactured by Pharming Healthcare Inc..
Key Facts
- Brand Name
- Ruconest
- Generic Name
- c1 esterase inhibitor recombinant
- NDC Code (Product)
71274-350- Manufacturer
- Pharming Healthcare Inc.
- Strength
- 2100 U/1
- Dosage Form
- INJECTION, POWDER, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA125495
- Marketing Start
- 04/01/2018
Recall History
No Recall HistoryFrequently Asked Questions
What is Ruconest used for?
Ruconest contains c1 esterase inhibitor recombinant. It is a injection, powder, for solution taken intravenous. Consult your doctor for specific uses.
Is Ruconest a controlled substance?
Ruconest is not classified as a controlled substance by the DEA.
What is the generic name for Ruconest?
The generic name for Ruconest is c1 esterase inhibitor recombinant. There are no other listed brand versions of c1 esterase inhibitor recombinant.
What is the NDC code for Ruconest 2100 U/1?
The NDC (National Drug Code) for Ruconest 2100 U/1 is 71274-350, listed by Pharming Healthcare Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)